Teladoc Health (TDOC) Short Interest Ratio & Short Volume $8.43 +0.38 (+4.68%) Closing price 06/27/2025 03:59 PM EasternExtended Trading$8.68 +0.25 (+3.00%) As of 07:39 AM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Short Interest Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock Teladoc Health Short Interest DataTeladoc Health (TDOC) has a short interest of 21.57 million shares, representing 12.37% of the float (the number of shares available for trading by the public). This marks a -6.42% decrease in short interest from the previous month. The short interest ratio (days to cover) is 3.7, indicating that it would take 3.7 days of the average trading volume of 6.31 million shares to cover all short positions.Current Short Interest21,570,000 sharesPrevious Short Interest23,050,000 sharesChange Vs. Previous Month-6.42%Dollar Volume Sold Short$148.29 millionShort Interest Ratio3.7 Days to CoverLast Record DateJune 15, 2025Outstanding Shares175,430,000 sharesShort Percent of Float12.37%Today's Trading Volume18,170,643 sharesAverage Trading Volume6,314,826 sharesToday's Volume Vs. Average288% Short Selling Teladoc Health? Sign up to receive the latest short interest report for Teladoc Health and its competitors with MarketBeat's FREE newsletter. Email Address Skip Charts & View Short Interest HistoryShort Interest ChartDays to Cover ChartShort Percent of Float ChartTDOC Short Interest Over TimeTDOC Days to Cover Over TimeTDOC Percentage of Float Shorted Over Time Teladoc Health Short Interest History Export to ExcelReport DateTotal Shares Sold ShortDollar Volume Sold ShortChange from Previous ReportPercentage of Float ShortedDays to CoverPrice on Report Date 6/15/202521,570,000 shares $148.29 million -6.4%12.4%3.7 $6.88 5/31/202523,050,000 shares $159.51 million +6.7%13.5%4.3 $6.92 5/15/202521,610,000 shares $157.32 million +3.4%12.7%3.5 $7.28 4/30/202520,900,000 shares $149.64 million +3.3%N/A2.6 $7.16 4/15/202520,230,000 shares $145.55 million -6.9%11.9%2.6 $7.20 3/31/202521,720,000 shares $173.20 million -19.0%12.7%2.8 $7.97 3/15/202526,820,000 shares $231.32 million +7.2%15.7%3.7 $8.63 2/28/202525,020,000 shares $239.19 million +13.6%14.7%3.5 $9.56 2/15/202522,020,000 shares $316.10 million -4.0%12.9%3.3 $14.36 1/31/202522,930,000 shares $232.85 million -2.4%N/A4.2 $10.16 Get the Latest News and Ratings for TDOC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Teladoc Health and its competitors with MarketBeat's FREE daily newsletter. 1/15/202523,500,000 shares $219.96 million -0.1%N/A4.5 $9.36 12/31/202423,530,000 shares $213.89 million +3.6%N/A4.5 $9.09 12/15/202422,710,000 shares $236.64 million -13.5%N/A4.2 $10.42 11/30/202426,240,000 shares $314.36 million +2.1%N/A4.7 $11.98 11/15/202425,690,000 shares $236.22 million -4.6%N/A4.4 $9.20 10/31/202426,930,000 shares $241.29 million +6.6%N/A4.9 $8.96 10/15/202425,260,000 shares $240.35 million -8.6%N/A4.3 $9.52 9/30/202427,640,000 shares $253.74 million +2.4%N/A4.5 $9.18 9/15/202427,000,000 shares $218.43 million +0.1%N/A3.9 $8.09 8/31/202426,970,000 shares $193.37 million -7.7%N/A4 $7.17 8/15/202429,210,000 shares $206.22 million -12.7%N/A4.5 $7.06 7/31/202433,460,000 shares $315.86 million -4.1%N/A5.2 $9.44 7/15/202434,880,000 shares $324.04 million +14.5%N/A6 $9.29 6/30/202430,470,000 shares $298.00 million +12.6%N/A5.5 $9.78 6/15/202427,060,000 shares $270.60 million -3.4%N/A5.3 $10.00 5/31/202428,020,000 shares $315.23 million +3.6%N/A6.1 $11.25 5/15/202427,040,000 shares $347.19 million -3.2%N/A5.4 $12.84 4/30/202427,920,000 shares $355.84 million +4.1%N/A5.2 $12.75 4/15/202426,810,000 shares $363.01 million +28.4%N/A5.5 $13.54 3/31/202420,880,000 shares $315.29 million +3.0%N/A4.4 $15.10 3/15/202420,280,000 shares $306.53 million -6.1%N/A4.4 $15.12 2/29/202421,600,000 shares $325.73 million +5.3%N/A4.5 $15.08 2/15/202420,510,000 shares $443.22 million +6.7%N/A4.3 $21.61 1/31/202419,230,000 shares $373.45 million -16.3%N/A4.8 $19.42 1/15/202422,980,000 shares $479.59 million +18.4%N/A4.8 $20.87 12/31/202319,410,000 shares $418.29 million -4.8%N/A4.1 $21.55 12/15/202320,390,000 shares $418.00 million +8.5%N/A4.2 $20.50 11/30/202318,790,000 shares $340.85 million -0.3%N/A3.8 $18.14 11/15/202318,850,000 shares $330.44 million -9.9%N/A4.1 $17.53 10/31/202320,930,000 shares $346.39 million -13.6%N/A4.5 $16.55Trump’s unwinnable war (Ad)Over the years, we’ve been dragged into a long line of wars. The war on drugs. The war on terror. Wars with no clear goal, no endgame… no real answers for why we were fighting them in the first place. Trillions spent, countless young lives lost, and what do we have to show for it? And now, as yet another conflict erupts in the Middle East and billions more are burned in foreign sand, I urge you: Do not be distracted. A war they said they would finally win for the American people. But that promise has been broken. 10/15/202324,220,000 shares $448.31 million -4.2%N/A4.5 $18.51 9/30/202325,290,000 shares $470.14 million -7.2%N/A4.6 $18.59 9/15/202327,260,000 shares $577.37 million -6.8%N/A5 $21.18 8/31/202329,260,000 shares $662.74 million +5.4%N/A5.6 $22.65 8/15/202327,760,000 shares $648.61 million -0.2%N/A5.2 $23.37 7/31/202327,820,000 shares $828.20 million +5.7%N/A5.4 $29.77 7/15/202326,310,000 shares $651.70 million +3.8%N/A6.4 $24.77 6/30/202325,360,000 shares $641.99 million +0.1%N/A6.4 $25.32 6/15/202325,330,000 shares $638.44 million -3.4%N/A7 $25.21 5/31/202326,210,000 shares $606.50 million -0.8%N/A7.2 $23.14 5/15/202326,430,000 shares $654.14 million -1.7%N/A6.8 $24.75 4/30/202326,890,000 shares $713.39 million +3.6%N/A6.8 $26.53 4/15/202325,960,000 shares $664.32 million -3.2%N/A6.5 $25.59 3/31/202326,810,000 shares $694.38 million +4.3%N/A6.8 $25.90 3/15/202325,700,000 shares $642.50 million +2.1%N/A6 $25.00 2/28/202325,170,000 shares $666.75 million -9.8%N/A5.8 $26.49 2/15/202327,890,000 shares $891.64 million +0.8%N/A6.2 $31.97 1/31/202327,680,000 shares $813.79 million -6.7%N/A6.3 $29.40 1/15/202329,660,000 shares $798.45 million +4.0%N/A6.5 $26.92 12/30/202228,520,000 shares $674.50 million -1.5%N/A6.1 $23.65 12/15/202228,940,000 shares $780.22 million -1.3%N/A6.3 $26.96 11/30/202229,330,000 shares $836.20 million -2.8%N/A6.2 $28.51 11/15/202230,180,000 shares $985.98 million -4.1%N/A6.6 $32.67 10/31/202231,470,000 shares $932.77 million -4.9%N/A6.8 $29.64 10/15/202233,080,000 shares $766.13 million -1.0%N/A6.6 $23.16 9/30/202233,400,000 shares $846.69 million +4.0%N/A6.8 $25.35 9/15/202232,120,000 shares $1.02 billion -4.3%N/A6.3 $31.89 8/31/202233,550,000 shares $1.04 billion +5.9%N/A6.4 $31.06 8/15/202231,680,000 shares $1.30 billion +4.3%N/A5.8 $40.93 7/31/202230,380,000 shares $1.12 billion -8.8%N/A4.8 $36.85 7/15/202233,300,000 shares $1.35 billion -7.9%N/A4 $40.58 6/30/202236,170,000 shares $1.20 billion -1.3%N/A4.4 $33.21 6/15/202236,650,000 shares $1.13 billion -0.5%N/A4.7 $30.96 5/31/202236,840,000 shares $1.26 billion -3.6%N/A4.8 $34.09 5/15/202238,200,000 shares $1.28 billion +37.4%N/A4.8 $33.59 4/30/202227,800,000 shares $938.53 million +9.0%18.1%3.8 $33.76 4/15/202225,500,000 shares $1.66 billion +2.3%16.6%5.9 $65.18 3/31/202224,920,000 shares $1.80 billion -3.0%16.3%5.5 $72.13 3/15/202225,700,000 shares $1.40 billion +7.6%16.8%5.6 $54.53 2/28/202223,880,000 shares $1.81 billion +1.3%15.6%5.2 $75.91 2/15/202223,570,000 shares $1.77 billion +9.0%15.4%5.1 $74.93 1/31/202221,620,000 shares $1.66 billion +0.4%14.6%5 $76.71 1/15/202221,530,000 shares $1.71 billion +4.9%14.6%5.1 $79.57 12/31/202120,530,000 shares $1.89 billion -15.8%13.9%5.3 $91.82 12/15/202124,390,000 shares $2.27 billion +7.6%16.5%6.7 $92.94 11/30/202122,670,000 shares $2.30 billion +7.8%15.3%6.7 $101.25 11/15/202121,030,000 shares $2.84 billion +1.3%14.2%7.5 $134.93 10/29/202120,770,000 shares $3.11 billion +1.1%14.3%9 $149.59 10/15/202120,540,000 shares $2.78 billion +7.1%14.2%9.1 $135.40 9/30/202119,180,000 shares $2.43 billion +7.9%13.3%8.5 $126.81Trump’s unwinnable war (Ad)Over the years, we’ve been dragged into a long line of wars. The war on drugs. The war on terror. Wars with no clear goal, no endgame… no real answers for why we were fighting them in the first place. Trillions spent, countless young lives lost, and what do we have to show for it? And now, as yet another conflict erupts in the Middle East and billions more are burned in foreign sand, I urge you: Do not be distracted. A war they said they would finally win for the American people. But that promise has been broken. 9/15/202117,770,000 shares $2.38 billion +2.0%12.3%7.8 $133.96 8/31/202117,430,000 shares $2.52 billion +0.6%12.1%7.9 $144.42 8/13/202117,320,000 shares $2.49 billion -2.7%12.2%7.1 $144.00 7/30/202117,800,000 shares $2.64 billion +2.2%12.5%6.6 $148.45 7/15/202117,420,000 shares $2.55 billion +1.2%12.6%5.9 $146.21 6/30/202117,220,000 shares $2.86 billion -1.9%12.4%5.8 $166.29 6/15/202117,550,000 shares $2.68 billion -0.9%12.7%5.6 $152.43 5/28/202117,710,000 shares $2.67 billion -7.2%12.8%5.4 $150.58 5/14/202119,080,000 shares $2.53 billion +13.4%N/A5 $132.71 4/30/202116,820,000 shares $2.87 billion +1.3%N/A4.5 $170.86 4/15/202116,600,000 shares $3.12 billion +4.9%N/A4.8 $188.11 3/31/202115,820,000 shares $2.76 billion +27.4%N/A4.3 $174.74 3/15/202112,420,000 shares $2.46 billion +11.0%N/A3.4 $197.95 2/26/202111,190,000 shares $2.46 billion +0.3%N/A3.3 $219.55 2/12/202111,160,000 shares $3.17 billion -4.9%N/A3.7 $283.69 1/29/202111,740,000 shares $3.09 billion -22.9%N/A3.5 $262.84 1/15/202115,230,000 shares $3.43 billion -0.6%N/A4.1 $225.54 12/31/202015,320,000 shares $3.12 billion -0.3%N/A4.6 $203.57 12/15/202015,370,000 shares $2.99 billion -0.1%N/A4.8 $194.63 11/30/202015,390,000 shares $3.02 billion +0.1%N/A4.8 $196.45 11/15/202015,370,000 shares $2.81 billion -7.0%N/A4.6 $183.07 10/30/202016,520,000 shares $3.60 billion +1.7%N/A4.7 $217.89 10/15/202016,250,000 shares $3.74 billion +1.1%N/A4.5 $230.45 9/30/202016,080,000 shares $3.53 billion +1.6%N/A4.5 $219.24 9/15/202015,830,000 shares $3.08 billion +14.8%N/A4.3 $194.71 8/31/202013,790,000 shares $2.97 billion +12.3%N/A3.7 $215.69 8/14/202012,280,000 shares $2.30 billion +78.5%N/A3.3 $187.50 7/31/20206,880,000 shares $1.63 billion -8.9%N/A2 $237.63 7/15/20207,550,000 shares $1.67 billion +0.7%N/A2.7 $221.83 6/30/20207,500,000 shares $1.43 billion -6.8%N/A2.5 $190.84 TDOC Short Interest - Frequently Asked Questions What is Teladoc Health's current short interest? Short interest is the volume of Teladoc Health shares that have been sold short but have not yet been covered or closed out. As of June 15th, traders have sold 21,570,000 shares of TDOC short. 12.37% of Teladoc Health's shares are currently sold short. Learn More on Teladoc Health's current short interest. What is a good short interest ratio for Teladoc Health? The short interest ratio, also known as the "days to cover ratio", is calculated by dividing the number of shares of a stock sold short divided by its average trading volume. A short interest ratio ranging between 1 and 4 generally indicates strong positive sentiment about a stock and a lack of short sellers. A short interest ratio of 10 or greater indicates strong pessimism about a stock. TDOC shares currently have a short interest ratio of 4.0. Learn More on Teladoc Health's short interest ratio. Which institutional investors are shorting Teladoc Health? As of the most recent reporting period, the following institutional investors, funds, and major shareholders have reported short positions of Teladoc Health: Jane Street Group LLC, Parallax Volatility Advisers L.P., Cubist Systematic Strategies LLC, Nomura Holdings Inc., PEAK6 LLC, Walleye Trading LLC, Walleye Capital LLC, Capital Fund Management S.A., Simplex Trading LLC, Parker Investment Management LLC, and IMC Chicago LLC. These positions are disclosed in Form 13F filings with the Securities and Exchange Commission. What is a good short interest percentage for Teladoc Health? Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 12.37% of Teladoc Health's floating shares are currently sold short. Is Teladoc Health's short interest increasing or decreasing? Teladoc Health saw a drop in short interest in June. As of June 15th, there was short interest totaling 21,570,000 shares, a drop of 6.4% from the previous total of 23,050,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment. How does Teladoc Health's short interest compare to its competitors? 12.37% of Teladoc Health's shares are currently sold short. Here is how the short interest of companies in the industry of "healthcare" compare to Teladoc Health: Option Care Health, Inc. (3.55%), RadNet, Inc. (9.35%), BrightSpring Health Services, Inc. (16.42%), Sotera Health Company (8.40%), Privia Health Group, Inc. (3.18%), Surgery Partners, Inc. (12.40%), GeneDx Holdings Corp. (15.03%), Veracyte, Inc. (7.69%), Addus HomeCare Corporation (4.13%), PACS Group, Inc. (7.13%), Which stocks are the most shorted right now? As of the most recent reporting period, the following stocks had the largest short interest positions: SPDR S&P 500 ETF Trust ($69.26 billion), Invesco QQQ ($25.22 billion), iShares Russell 2000 ETF ($20.33 billion), iShares 20+ Year Treasury Bond ETF ($9.99 billion), MicroStrategy Incorporated ($9.12 billion), Canadian Natural Resources Limited ($6.73 billion), SPDR S&P Biotech ETF ($6.52 billion), Invesco S&P 500 Equal Weight ETF ($5.60 billion), Financial Select Sector SPDR Fund ($4.64 billion), and iShares iBoxx $ Investment Grade Corporate Bond ETF ($4.59 billion). View all of the most shorted stocks. What does it mean to sell short Teladoc Health stock? Short selling TDOC is an investing strategy that aims to generate trading profit from Teladoc Health as its price is falling. TDOC shares are trading up $0.38 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit. How does a short squeeze work against Teladoc Health? A short squeeze for Teladoc Health occurs when it has a large amount of short interest and its stock increases in price. This forces short sellers to cover their short interest positions by buying actual shares of TDOC, which in turn drives the price of the stock up even further. How often is Teladoc Health's short interest reported? Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TDOC, twice per month. The most recent reporting period available is June, 15 2025. More Short Interest Resources from MarketBeat Related Companies Option Care Health Short Interest RadNet Short Interest BrightSpring Health Services Short Interest Sotera Health Short Interest Privia Health Group Short Interest Surgery Partners Short Interest GeneDx Short Interest Veracyte Short Interest Addus HomeCare Short Interest PACS Group Short Interest Short Interest Tools Stocks to Short Largest Short Interest Positions Short Interest Increases Short Interest Decreases Short Interest Reporting Dates This page (NYSE:TDOC) was last updated on 6/30/2025 by MarketBeat.com Staff From Our PartnersCrypto Is Pumping Again – Now Comes the Real OpportunityThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | Sponsored3..2..1.. AI 2.0 ignition (don’t sleep on this)I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | SponsoredAI Meltdown Imminent: Dump These Stocks Now!If you have any money in the markets, especially in AI stocks… Please click here to see Elon Musk’s new inv...Paradigm Press | SponsoredWhy Is President Trump Fast-Tracking These Companies?Forget about AI… There's a hot new trend on Wall Street… And it's all thanks to President Trump. His ...InvestorPlace | SponsoredBuffett’s $325 Billion Cash Problem — Solved by Gold?A bombshell announcement is just weeks away — and it could send shockwaves through the gold market. Most inves...Golden Portfolio | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | Sponsored379 passengers walked away from thisElon Musk just wrote a $51 million check to back this material’s next phase… Because it’s not just saving l...True Market Insiders | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Teladoc Health, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Teladoc Health With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
